african biotech
Yemaachi News
February 14, 2023
As one of Ghana's only labs equipped for molecular analysis, Bediako's team have tasked themselves with collecting data they believe will advance the development of medicine for cancer patients throughout the continent and diaspora
November 29, 2022
As one of Ghana's only labs equipped for molecular analysis, Bediako's team have tasked themselves with collecting data they believe will advance the development of medicine for cancer patients throughout the continent and diaspora
May 25, 2022
As one of Ghana's only labs equipped for molecular analysis, Bediako's team have tasked themselves with collecting data they believe will advance the development of medicine for cancer patients throughout the continent and diaspora
March 21, 2022
Yemaachi Biotech announced today the close of a $3 million seed round to advance its mission of diversifying precision oncology globally. V8 Capital led the round, with LifeLine Family Heritage Fund, Y Combinator, Tencent, LoftyInc Capital, VestedWorld, V Square Capital and Ethan Perlstein also participating.
July 1, 2021
Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab